Implications of Health Care Providers by Physicians’ and Pharmacists’ Attitudes and Perceptive Barriers towards Interprofessional Collaborative Practices
DOI:
https://doi.org/10.1590/s2175-97902022e20983Keywords:
Attitudes, Interprofessional collaboration, Iraq, Pharmacists, PhysiciansAbstract
The study was aimed at assessing and comparing physicians’ and pharmacists’ attitudes and experiences with collaborative practices, along with the extent of barriers toward interprofessional collaboration in Iraqi healthcare settings. A descriptive, cross-sectional study was conducted among physicians and pharmacists in different healthcare settings in Baghdad, Iraq through an interview using a structured 3-part questionnaire, assessing the demographic characteristics, attitudes and barriers to interprofessional collaborative practices. A total of 384 participants were enrolled in this study. The physicians and pharmacists reported a significant positive attitudes towards collaboration, such as ‘’pharmacists are qualified to assess and respond to patients’ drug treatment needs’’ (69.8%, vs. 89.6%,; P=0.001);‘’pharmacists have special expertise in counseling patients on drug treatment’’ (59.9%, vs. 86%; P=0.001); ‘’physicians and pharmacists should be educated to establish collaborative relationships’’ (80.7%, vs. 100%; P=0.001), respectively. However, 57.3% of the physicians agreed about ‘‘lack or inadequate of pharmacists’ time to provide direct and effective patient care because of medications dispensing duties’’, while 56.8% of the pharmacists disagreed about this barrier (P=0.005). Both professions reported significant, positive attitudes and shared some barriers toward collaborative practices; however, there is a disagreement in some areas in which both professions would like more collaboration for better patient care.
Downloads
References
Adnan S, Tanwir S, Abbas A, Beg AE, Sabah A, Safdar H, et al. Perception of doctors regarding patient counseling by pharmacist: a blend of quantitative and qualitative insight. Int J Pharm Ther. 2014;5(2):117-21.
Alkhateeb FM, Unni E, Latif D, Shawaqfeh MS, Al-Rousan RM. Physician attitudes toward collaborative agreements with pharmacists and their expectations of community pharmacists’ responsibilities in West Virginia. J Am Pharm Assoc (2003) . 2009;49(6):797-800.
Al-Taie A, Abdulrazzaq HA, Yılmaz ZK, Izzettin FV, Koramaz N, Yılmaz KC. Predictors and differences in patients’ self-reporting types to adverse symptomatic events. Eur J Clin Pharm.2016;18(2):130-35.
AL-Taie A, Izzettin FV, Sancar M, Köseoğlu A. Impact of clinical pharmacy recommendations and patient counselling program among patients with diabetes and cancer in outpatient oncology setting. Eur J Cancer Care. 2020;29(5):e13261.
Al-Taie A, Köseoğlu A. Determination of radiotherapy-related acute side effects; a starting point for the possible implementation of a clinical pharmacy services in the radiological unit in turkey. J Young Pharm. 2019;11(4):434-38.
Al-Taie A, Köseoğlu A. Incidence of early related- complications of port-A catheter and impact of clinical pharmacist participation and counselling outcomes. J Young Pharm . 2018;10(2):218-21.
Beardsley RS, Kimberlin CL, Tindall WN. Communication Skills in Pharmacy Practice: A Practical Guide for Students and Practitioners. 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA 19106 USA; 2008.
Berenguer B, La Casa C, de la Matta MJ, Martín-Calero MJ. Pharmaceutical care: past, present and future. Curr Pharm Des. 2004;10(31):3931-3946.
Cochran WG. Sampling techniques (3rd ed.). New York, John Wiley & Sons, 1977.
El-Ibiary SY, Yam L, Lee KC. Assessment of burnout and associated risk factors among pharmacy practice faculty in the United States. Am J Pharm Educ. 2017;81(4):75.
Ernawati D, Ping Lee Y, Hughes J. Indonesian students’ participation in an interprofessional learning workshop. J Interprof Care. 2015;29(4):398-400.
Farrell B, Pottie K, Woodend K, Yao V, Dolovich L, Kennie N, et al. Shifts in expectations: evaluating doctors’ perceptions as pharmacists become integrated into family practice. J Interprof Care . 2010;24(1):80-9.
Gallagher RM, Gallagher HC. Improving the working relationship between doctors and pharmacists: is inter-professional education the answer? Adv Health Sci Educ. 2012;17(2):247-57.
Guthrie KD, Stoner SC, Hartwig DM, May JR, Nicolaus SE, Schramm AM,et al. Physicians’ Preferences for Communication of Pharmacist-Provided Medication Therapy Management in Community Pharmacy. J Pharm Pract. 2017;30(1):17-24.
Hirsch JD, Steers N, Adler DS, Kuo GM, Morello CM, Lang M, et al. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014;36(9):1244-1254.
Hojat M, Gonnella JS. An instrument for measuring pharmacist and physician attitudes towards collaboration: preliminary psychometric data. J Interprof Care . 2011;25(1):66-72.
Hojat M, Spandorfer J, Isenberg GA, Fassihi R, Gonnella JS. Psychometrics of the scale of attitudes toward physician- pharmacist collaboration: A study with medical students. Med Teach. 2012;34(12):e833-37.
Howard M, Trim K, Woodward C, Dolovich L, Sellors C, Kaczorowski J, Sellors J. Collaboration between community pharmacists and family physicians: lessons learned from the Seniors Medication Assessment Research Trial. J Am Pharm Assoc . (2003). 2003;43(5):566-72.
Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med. 2003;163(15):1813-20.
Izzettin FV, Al-taie A, Sancar M, Aliustaoğlu M. Influence of pharmacist recommendations for chemotherapy-related problems in diabetic cancer patients. Marmara Pharm J. 2017;21(3):603-11.
Kelly DV, Bishop L, Young S, Hawboldt J, Phillips L, Keough TM. Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project. Can Pharm J (Ott). 2013;146(4):218-26.
Kuo GM, Buckley TE, Fitzsimmons DS, Steinbauer JR. Collaborative drug therapy management services and reimbursement in a family medicine clinic. Am J Health Syst Pharm. 2004;61(4):343-54.
Laubscher T, Evans C, Blackburn D, Taylor J, McKay S. Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications. Can Fam Physician. 2009;55(12):e69-e75.
Lauffenburger JC, Vu MB, Burkhart JI, Weinberger M, Roth MT. Design of a medication therapy management program for Medicare beneficiaries: qualitative findings from patients and physicians. Am J Geriatr Pharmacother. 2012;10(2):129-37.
Mann C. Doctors need to give up professional protectionism. BMJ. 2018;361:k1757.
McGrath SH, Snyder ME, Dueñas GG, Pringle JL, Smith RB, McGivney MS. Physician perceptions of pharmacist-provided medication therapy management: qualitative analysis. J Am Pharm Assoc (2003) . 2010;50(1):67-71.
Mekonnen AB, McLachlan AJ, Joanne EB. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and metaanalysis. BMJ open. 2016;6(2):e010003.
Mohammed NH, Al-Taie A, Albasry Z. Evaluation of goserelin effectiveness based on assessment of inflammatory cytokines and symptoms in uterine leiomyoma. Int J Clin Pharm. 2020;42(3):931-37.
Norwood CW, Wright ER. Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: improving clinical decision-making and supporting a pharmacist’s professional judgment. Res Social Adm Pharm. 2016;12(2):257-66.
Olsson E, Kalvemark Sporrong S. Pharmacists’ experiences and attitudes regarding generic drugs and generic substitution: two sides of the coin. Int J Pharm Pract . 2012;20(6):377-83.
Pojskic N, MacKeigan L, Boon H, Ellison P, Breslin C. Ontario family physician readiness to collaborate with community pharmacists on drug therapy management: lessons for pharmacists. Can Pharm J (Ott) . 2009;142:184-9.
Pottie K, Farrell B, Haydt S, Dolovich L, Sellors C, Kennie N, Hogg W, et al. Integrating pharmacists into family practice teams: physicians’ perspectives on collaborative care. Can Fam Physician . 2008;54(12): 1714-1717.e5.
Rosenthal M, Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J Rev Pharm Can. 2010;143(1):37-42.
World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310(20):2191-94.
Wuensch KL. Chi-Square Tests. In: Lovric M . (eds) International Encyclopedia of Statistical Science. Springer, Berlin, Heidelberg, 2011.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
